跳至主要内容
临床试验/NCT02201225
NCT02201225已完成1 期

A Methodology Study to Evaluate a Sitting Knee Measuring Device in Assessing Growth in Indian Children Aged 6 to 12 Years Receiving Nutritional Supplement With or Without Micronutrient Fortification

GlaxoSmithKline1 个研究点 分布在 1 个国家目标入组 109 人开始时间: 2014年10月1日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
109
试验地点
1
主要终点
Change from Baseline to Week 12 in bone growth, as measured by sitting knee length caliper.

研究概览

简要总结

This methodology study will evaluate the sensitivity in using sitting knee digital caliper to measure changes in sitting knee length from over a 12-week study period amidst children in the age of 6 to 12 years in a community-based study in children ages 6 to 12 years who are receiving nutritional supplementation with micronutrients or without micronutrients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
6 Years 至 12 Years(Child)
性别
All
接受健康志愿者
是

入选标准

  • •Children (participants), both boys and girls, aged 6 to 12 years.
  • •Participant height to be within the 25th to the 75th percentile of the standard height average in Indian children population
  • •Participant will agree not to take any other nutritional supplements products during the study except the trial supplement

排除标准

  • •Participant has any of the following medical conditions: Genetic disorders, chronic disease, metabolic disorders, endocrine disorders, immobilisation, and miscellaneous
  • •Participant who in the past 6 months has used dietary or nutritional supplements with micronutrient fortification, or any form of dietary or herbal supplement intended to increase micronutrient intake, at a frequency of greater than 3-4times per month.
  • •Participant receiving any supplements (such as calcium, iron and/or multivitamin at the time of screening).
  • •Children (Participant) in Care are not allowed to participate in the study.
  • •Allergy/Intolerance: Known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients.
  • •Health conditions that would affect food metabolism including the following food allergies, kidney disease, liver disease, and/or gastrointestinal diseases (e.g. irritable bowel syndrome, celiac disease, peptic ulcers).
  • •Use of concomitant medications that, in the opinion of the Principal Investigator (PI), might interfere with the outcome of the study or increases the risk of the participant, including corticosteroids (systemic or inhaled) and any medication for any behaviour-related disorders and/or stimulants.
  • •Current or relevant history of any serious, severe or unstable physical or psychiatric illness or any medical disorder, including history of alcohol or substance abuse, that would make the participant unlikely to fully complete the study or any condition that presents undue risk from the study product or procedures in the opinion of the PI/medical examiner.
  • •Clinical Study/Experimental Medication: Participation in another clinical study or receipt of an investigational drug within 30 days of the screening visit.
  • •Personnel: Currently, the participant's parents/legal guardian is an employee of the Sponsor or the study or members of their immediate family.

研究组 & 干预措施

Nutritional supplement with micronutrient

Active Comparator

Nutritional supplement powder with micronutrients packed as 27 g individual sachet, administered orally as a single serve twice daily

干预措施: Nutritional supplement with micronutrient (Dietary Supplement)

Nutritional supplement without micronutrient

Sham Comparator

Nutritional supplement powder without micronutrients packed as 27 g individual sachet, administered orally as a single serve twice daily

干预措施: Nutritional supplement without micronutrient (Dietary Supplement)

结局指标

主要结局

Change from Baseline to Week 12 in bone growth, as measured by sitting knee length caliper.

时间窗: Baseline to Week 12

To evaluate the sensitivity of a sitting knee digital caliper to measure changes in sitting knee length from Baseline to Week 12 in a community-based study in the presence of nutritional supplementation with or without micronutrients.

次要结局

  • Change from Baseline to Week 8 in bone growth, as measured by sitting knee length digital caliper(Baseline-Week 8)
  • Change from Baseline to Week 12 in Z-score based on the standing height(Baseline-Week 12)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验